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Abstract 
Background: The ESX secretion system, also known as the Type VII secretion system, is mostly found in mycobacteria 
and plays important roles in nutrient acquisition and host pathogenicity. One of the five ESXs, ESX‑3, is associated 
with mycobactin‑mediated iron acquisition. Although the functions of some of the membrane‑associated com‑
ponents of the ESX systems have been described, the role of by mycosin‑3 remains elusive. The esx‑3 gene cluster 
encoding ESX‑3 in both Mycobacterium tuberculosis and Mycobacterium smegmatis has two promoters, suggesting the 
presence of two transcriptional units. Previous studies indicated that the two promoters only showed a difference in 
response under acid stress (pH 4.2). This study aimed to study the effect of a mycosin‑3 deletion on the physiology of 
M. smegmatis and to assess the promoter activities in wildtype, mycosin‑3 mutant and complementation strains.
Results: The gene mycP3 was deleted from wildtype M. smegmatis via homologous recombination. The mycP3 gene 
was complemented in the deletion mutant using each of the two intrinsic promoters from the M. smegmatis esx‑
3 gene cluster. The four strains were compared in term of bacterial growth and intracellular iron content. The two 
promoter activities were assessed under iron‑rich, iron‑deprived and iron‑rescued conditions by assessing the mycP3 
expression level. Although the mycP3 gene deletion did not significantly impact bacterial growth or intracellular iron 
levels in comparison to the wild‑type and complemented strains, the two esx‑3 promoters were shown to respond 
inversely to iron deprivation and iron rescue.
Conclusion: This finding correlates with the previously published data that the first promoter upstream of 
msmeg0615, is upregulated under low iron levels but downregulated under high iron levels. In addition, the second 
promoter, upstream of msmeg0620, behaves in an inverse fashion to the first promoter implying that the genes down‑
stream may have additional roles when the iron levels are high.
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Background
Tuberculosis, whose etiological agent is Mycobacterium 
tuberculosis (Mtb), was one of the top ten causes of death 
worldwide in 2015 (1.4 million deaths) [1]. Such a tre-
mendous medical burden is exacerbated by the emer-
gence of multidrug-resistant TB (MDR-TB), thus new 
drug target is urgently needed for new anti-TB treatment 
development. An ideal drug target should be responsible 
for essential metabolic functions in Mtb and it should 
have no homology to human proteins to minimize drug 
toxicity to the host. The Type VII secretion systems, or 
ESXs (with five members ESX-1 to -5), are a signature 
group of protein secretion systems in mycobacteria. They 
have been extensively studied, especially ESX-1, -3 and 
-5, because they are responsible for bacterial survival and 
pathogenicity during Mtb infection [2]. Unlike ESX-1 and 
ESX-5, ESX-3 is most conserved in both pathogenic and 
environmental mycobacteria, and it is associated with 
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mycobactin-mediated (an iron chelator secreted by the 
mycobacteria) iron acquisition [3–5], and also affects 
heme acquisition [6]. Abolishing both pathways would be 
a promising anti-tuberculosis therapeutic strategy [7].
The expression of the esx-3 gene cluster in M. tuber-
culosis and M. smegmatis is governed by two promoters, 
the first located upstream of the first gene of the cluster 
(msmeg_0615) and the second located upstream of the 
esx genes (msmeg_0620 and msmeg_0621) [8] (Fig.  1). 
The first promoter is controlled by the transcriptional 
regulator IdeR in an iron-dependent manner [9]. The 
regulator of the second promoter has not been identi-
fied. Previously, the activities of the two promoters in 
M. smegmatis were only shown to differ in response to 
acid stress (pH 4.2) and no difference was observed under 
iron-rich or iron-deprived conditions [8].
Compared to the other membrane protein compo-
nents of the ESXs consisting of EccBCDE which consti-
tute the core membrane structure [10], the roles played 
by mycosins remain elusive [2]. It was found that  MycP1 
cleaves EspB upon secretion, possibly facilitating the 
maturation of ESX substrates [11]. The stability of both 
the ESX-1 and ESX-5 complex could be compromised 
if  MycP1 and  MycP5 respectively, were absent, suggest-
ing that mycosins are crucial for the integrity and func-
tioning of the ESX [12]. However, how they facilitate 
the substrate secretion for their respective ESX systems 
remained poorly understood. The functional study on 
 MycP3 is even more limited with no functional data pub-
lished in the literature. In this report, M. smegmatis was 
used as a model organism in which mycP3 was deleted 
to generate the deletion mutant, and the mycP3 comple-
mentation strains were generated from the mutant by 
introducing mycP3 downstream of each of the two esx-
3 promoters. This study investigated the impact of the 
mycP3 deletion on bacterial growth and intracellular iron 
content under different iron conditions, as well as the 
activities of the two promoters under these conditions.
Methods
Bacterial strains, culture media and plasmid DNA
Escherichia coli XL-1 blue (Stratagene, USA, Catalogue 
No. 200249) was used for manipulating and propagating 
recombinant plasmid DNA. Mycobacterium smegma-
tis  mc2 155 (a gift from Rob Warren, South Africa) was 
used as the parent wildtype strain  (WTms) from which 
the  MycP3 deletion mutant (ΔMycP3ms) was derived, and 
as template to generate two complementation strains 
(ΔMycP3ms::pr1MycP3ms and ΔMycP3ms::pr2MycP3ms). E. 
coli was cultured using both Lysogeny Broth (LB) liquid 
media [1% (w/v) tryptone (Merck, USA, Catalogue No. 
107213), 0.5% (w/v) yeast extract (Merck, USA, Cata-
log No. 113885), and 1% (w/v) sodium chloride (Sigma-
Aldrich, USA, Catalogue No. S7653)] and solid media 
[LB liquid media supplemented with 1.5% (w/v) bacte-
rial agar (Sigma-Aldrich, USA, Catalogue No. A5306)]. 
M. smegmatis was cultured using both Middlebrook 7H9 
liquid medium (Becton–Dickinson, USA, Catalogue No. 
221832) and Difco 7H11 solid medium (Becton–Dick-
inson, USA, Catalogue No. 212304) both supplemented 
with 0.05% (v/v) Tween 80 (Sigma Aldrich, USA, Cata-
logue No. P1754), 0.5% (w/v) glucose (Sigma Aldrich, 
USA, Catalogue No. 47829), and 0.5% (v/v) glycerol 
(Sigma-Aldrich, USA, Catalogue No. G5516). Fe-free 
7H9 (omitting ferric ammonium citrate) and Fe-free 
Sauton’s medium (3.5  mM  KH2PO4 (Sigma-Aldrich, 
USA, Catalogue No. NIST200B), 25  mM l-asparagine 
(Sigma-Aldrich, USA, Catalogue No. A0884), 10  mM 
citric acid (Sigma-Aldrich, USA, Catalogue No. 791725), 
4  mM  MgSO4·6H2O (Sigma-Aldrich, USA, Catalogue 
No. 746452), 5% (v/v) glycerol, and 0.05% (v/v) Tween-
80) were also used to monitor bacterial growth under 
iron-limiting condition. The iron depleted 7H9 and Sau-
ton’s media were prepared by mixing iron-free 7H9 and 
Sauton’s media (omitting  MgSO4·6H2O) with 10  g/L 
Chelex resin (Bio-Rad, USA, Catalogue No. 1422822), 
a chelating agent, for 48  h and then filter-sterilized 
and supplemented with sterile  MgSO4·6H2O (4  mM) 
before culturing M. smegmatis. Additionally, the iron 
deprivation rescuing of the M. smegmatis cultured in 
iron-deprived 7H9 or Sauton’s media was achieved by 
supplementation of ferric ammonium citrate in the same 
concentration of normal 7H9 or Sauton’s media.
The CloneJet1.2 vector (Thermofisher, USA, Catalogue 
No. K1231) was used for insert DNA amplification before 
cloning into the target vectors. The p2Nil suicide vector 
and the pGoal17 selection gene cassette [13] were used 
to generate ΔMycP3ms, and pMV306 [14] was used for 
 MycP3 complementation (the three vectors were pro-
vided by Rob Warren as a gift).
Fig. 1 Genetic organization of the esx‑3 gene cluster in Mycobacterium smegmatis. The positions of the promoters, pr1 and pr2, are 
indicated(Adapted from [8])
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Construction of M. smegmatis mycP3 gene knockout strain 
and corresponding complemented strains
Homologous DNA recombination was used to generate 
the ΔMycP3ms strain (unmarked in-frame deletion) as 
previously described [13]. One thousand basepair (bp) 
fragments upstream (UP) and downstream (DOWN) 
of mycP3ms gene (MSMEG_0624) were amplified using 
 Phusion® DNA polymerase (ThermoFisher, USA, Cata-
logue No. F532S) with two pairs of primers (Table  1). 
The thermo-cycling conditions for producing these two 
PCR products were as follows: initial denaturation step 
at 95  °C for 30  s; 40 cycles of amplification at 95  °C for 
5  s followed by 30  s at 60  °C and 1  min at 72  °C; final 
elongation step at 72  °C for 7 min. The UP and DOWN 
PCR fragments were blunt-end ligated into pJet1.2 vec-
tor individually according to the manufacturer’s instruc-
tions. The UP and DOWN DNA inserts were restriction 
digested out of pJet1.2 by HindIII/XhoI and XhoI/BamHI 
restriction enzyme pairs respectively. The DNA inserts 
were simultaneously ligated into p2Nil, previously 
digested with HindIII and BamHI, via three-way clon-
ing (three pieces of DNA joining together) using T4 DNA 
ligase (Promega, USA, Catalogue No. M1801), resulting 
in recombinant p2Nil-UP-DOWN plasmid DNA. The 
selection gene cassette  (PAg85-lacZ  Phsp60-sacB) from 
pGOAL17 was inserted at the PacI restriction site p2Nil-
UP-DOWN plasmid DNA and the final construct was 
electroporated into M. smegmatis  mc2  155 cells. Blue 
single-crossover colonies were selected on LB agar sup-
plemented with 50  μg/mL kanamycin (Sigma-Aldrich, 
USA, Catalogue No. 17151) and 0.2% X-gal (Sigma-
Aldrich, USA, Catalogue No. 11680293001). The colonies 
were picked and passaged in LB media in the absence 
of kanamycin to induce a second crossover event. Dou-
ble crossover colonies were selected on LB agar sup-
plemented with 5% sucrose (Sigma-Aldrich, USA, 
Catalogue No. E001888) and X-gal. White colonies were 
further screened by colony PCR using screening prim-
ers (Table 1) to distinguish between WT and ΔMycP3ms 
strains. The colony PCR thermo-cycling conditions were 
as follows: initial denaturation step at 95  °C for 30 s; 40 
cycles of amplification at 95 °C for 5 s followed by 30 s at 
58 °C and 1 min at 72 °C; final elongation step at 72 °C for 
7 min. The WT PCR product was approximately 1600 bp 
while that of the ΔMycP3ms was about 200 bp (Additional 
file 1: Figure S1a).
The M. smegmatis esx-3 gene cluster contains two pro-
moters, namely pr1 and pr2 which are upstream of the 
MSMEG_0615 and the MSMEG_0620 genes, respec-
tively (Fig.  1) [8]. Both promoters were used to make 
Table 1 Primers used for ΔMycP3ms generation,  MycP3 complementation and RT-qPCR assay
Experiment Gene related Primer name Primer sequence Restriction site (underlined)
ΔMycP3ms Generation mycP3 UP forward 5′‑AAGCTTTCCCACGCACATCG‑3′ HindIII
UP reverse 5′‑CTCG AGATCACCTGTCGAGCACG‑3′ XhoI
DOWN forward 5′‑CTCGAGATGACCGCCCGGATAGC‑3 XhoI
DOWN reverse 5′‑GGATCCCCGGTCTCGGTGAC‑3′ BamHI
ΔMycP3ms Construct verification mycP3 mycP3 screening forward 5′‑GCTCAACCCGAAGATC GCCTC‑3′ N/A
mycP3 screening reverse 5′‑AGGAACATGCCTTTCCACCAGG‑3′ N/A
MycP3 Complementa‑tion mycP3 pr1 forward 5′‑CCATGGGACGCTGAACGAGTGTTTAC‑3′ NcoI
pr1 reverse 5′‑GACGCCCAGACTCTTGTGGATCA‑
CATCGCGGTCGACCCGGGGCG‑3′
N/A
mycP3‑pr1 forward 5′‑CGCCCCGGGTCGACCGCGATGTGATC‑
CACAAGAGTCTGGGCGTC‑3′
N/A
mycP3 reverse 5′‑AAGCTTTCATGTGGTCTTGTCCTTCC‑3′ HindIII
pr2 forward 5′‑CCATGGACGTGGGACGGCGACGA 
GAATC‑3′
NcoI
pr2 reverse 5′‑GACGCCCAGACTCTTGTGGATCAC‑
GACTGTTTCC TTTCGAAGGTGGTG‑3′
N/A
mycP3‑pr2 forward 5′‑CACCACCTTCGAAAGGAAAC AGTCGT‑
GATCCACAAGAGTCTGGGCGTC‑3′
N/A
RT‑qPCR assay sigA sigA forward 5′‑GGGCGTGATGTCCATCTGCT‑3′ N/A
sigA reverse 5′‑GTATCCCGGTGCATGGTC‑3′
mycP3 mycP3 forward 5′‑GGATCATCGCGTTCGTGGGTAC‑3′
mycP3 reverse 5′‑GTCTTGTCCTTCCGACGGTAGG‑3′
eccE3 eccE3 forward 5′‑GAGCCGTTGTTGACGGTTTG‑3′
eccE3 reverse 5′‑GTTCGGTCGACAACGGGTTC‑3′
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complementation constructs expressing  MycP3 as pre-
viously described [15]. The PCR thermo-cycling condi-
tions for making the pr1, pr2 and  mycP3 respectively are 
as follows: initial denaturation step at 95 °C for 5 min, 40 
cycles of amplification at 95 °C for 5 s followed by 30 s at 
59 °C (pr1), 60 °C (pr2), and 62 °C (mycP3) and 1 min of 
elongation step at 72 °C; final elongation step at 72 °C for 
7 min. The four pairs of primers for making the two com-
plementation constructs in integrative pMV306 plasmid 
DNA are given in Table 1. The reverse primer sequences 
for amplifying the two promoters are partially com-
plementary to the sense primers of mycP3 to facilitate 
single-joint PCR [16] connecting pr1/pr2 and  MycP3ms. 
The thermo-cycling condition for single-joint PCR is as 
follows: initial denaturation step at 95  °C for 5  min, an 
annealing step at 55  °C for 15  min and the last elonga-
tion step at 72 °C for 3 min. The final joined PCR prod-
ucts were amplified using the following thermo-cycling 
condition: initial denaturation step at 95  °C for5  min, 
40 cycles of 95 °C for 5 s followed by 62 °C for 30 s and 
elongation step at 72  °C for 2  min, and final elongation 
step at 72  °C for 7 min. The final PCR products, named 
pr1-mycP3ms and pr2-mycP3ms were ligated into the 
pMV306 vector respectively using T4 DNA ligase. The 
recombinant pMV306-pr1-mycP3 and pMV306-pr2-
mycP3 plasmids were electroporated into the M. smeg-
matis ΔMycP3ms mutant strain to generate two  MycP3 
complementation strains, ΔMycP3ms::pr1mycP3ms and 
ΔMycP3ms::pr2mycP3ms. The genetic integrity of the WT, 
ΔMycP3ms and two complementation strains were con-
firmed by colony PCR (See Additional file 1: Figure S1a). 
The thermo-cycling condition for the colony PCR was the 
same as that of the WT and KO strains except the anneal-
ing temperature was at 62  °C. The eccE3 gene is directly 
downstream of the mycP3 gene with a tetra-nucleotide 
overlap. The expression level of eccE3 gene was assessed 
via RT-qPCR to ensure there was no polar effect from 
mycP3 deletion (See Additional file 1: Figure S1b).
Bacterial growth under iron‑rich and iron‑deprived 
conditions
M. smegmatis WT, ΔMycP3ms, ΔMycP3ms::pr1MycP3ms 
and ΔMycP3ms::pr2MycP3ms strains were cultured in 7H9 
broth, iron-free 7H9 broth and Sauton’s media, iron-che-
lated 7H9 and Sauton’s media from a starting  OD600nm of 
0.01. They were incubated at 37 °C with a rotating rate of 
200 rpm for 48 h during which the  OD600nm reading was 
taken every 3 h. Complete iron depletion of the culture 
was reached by sub-culuring the bacteria three times in 
iron-free 7H9 or Sauton’s media and then finally into the 
iron chelated 7H9 or Sauton’s media. The growth curves 
were performed in biological triplicate.
Intracellular iron quantitation
Intracellular iron quantitation was performed as previ-
ously described [17]. Fifty millilitres of bacterial cultures 
at mid-log phase  (OD600nm of 0.7–0.9) was harvested by 
centrifugation. The cell pellet was washed twice with 
cold Tris–HCl buffer [5  mM Tris (Sigma-Aldrich, USA, 
Catalogue No. T3253), pH 7.6, 0.005% (v/v) Tween 80] 
and then mixed with equal volume of 0.1 mm diameter 
glass beads (Biospec, USA, Catalogue No. 11079101) and 
resuspended in 500  μL 50  mM NaOH (Sigma-Aldrich, 
USA, Catalogue No. S8045). The mixture was ribolyzed 
using a  FastPrep®-24 ribolyzer (MP Biomedicals, USA) 
at 6.0  m/s for 30  s. This was repeated three times with 
30  s incubation on ice between each repeat. The whole 
cell lysate was cleared by centrifugation at 12,000×g at 
4  °C for 30  min. One hundred microliters of the whole 
cell lysate was used for the iron quantification assay and 
another 25  μL was used for protein quantitation using 
the RC-DC protein assay (Bio-rad, USA, Catalogue No. 
5000121). For iron quantitation, the whole cell lysate was 
transferred into one well of a 96-well microtiter plate 
and mixed with 100  μL of 10  mM HCl (Sigma-Aldrich, 
USA, Catalogue No. H3162) and then 100 μL iron-releas-
ing reagent [a freshly made solution of equal volumes 
of 1.4  M HCl and 4.5%,  KMnO4 (Sigma-Aldrich, USA, 
Catalogue No. 1.09121) in distilled water]. This mixture 
was incubated at 60 °C for 2 h, cooled to room tempera-
ture, and 30 μL of iron-detecting agent [6.5 mM ferrozine 
(Sigma-Aldrich, USA, Catalogue No. 160601), 6.5  mM 
neocuproine (Sigma-Aldrich, USA, Catalogue. N1501), 
2.5  M ammonium acetate (Sigma-Aldrich, USA, Cata-
logue No. A1542), and 1 M ascorbic acid (Sigma-Aldrich, 
USA, Catalogue No. A7506)] was added to the well and 
incubated for 30 min at room temperature. The absorb-
ance was read at 550 nm on a photospectrometer. Ferric 
chloride (Sigma-Aldrich, USA, Catalogue No. F2877) was 
used as iron standards at the concentration of 10–80 μM 
in 50 mM NaOH. The iron concentration was normalized 
against the protein content, which was done by divid-
ing the iron concentration by the protein concentration, 
resulting in the unit of nmol (of iron) per mg (of protein). 
The experiment was performed in triplicate.
RT‑qPCR
Fifteen millilitres of each M. smegmatis strain was har-
vested at mid-log phase in normal 7H9, Fe-free 7H9 
or Fe-rescued 7H9 by centrifugation. The superna-
tant was discarded and the pellet was resuspended in 
1  mL  FastRNA® Blue solution (MP Biomedicals, USA, 
Catalogue No. 6025-050) and ribolyzed as described 
above. The whole cell lysate was cleared by centrifuga-
tion at 12,000×g at 4  °C for 30  min, and 700  μL of the 
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supernatant was transferred into a new 1.5  mL tube 
and thoroughly mixed with 300  μL chloroform (Sigma-
Aldrich, USA, Catalogue No. C7559). The mixture was 
centrifuged at 12,000×g at 4  °C for 10  min. The top 
aqueous layer was transferred to a new 1.5 mL tube and 
mixed with 500  μL pre-chilled 100% ethanol (Sigma-
Aldrich, USA, Catalogue No. 900642). The mixture was 
transferred onto the RNA purification column from 
 NucleoSpin® RNA isolation kit (Macherey–Nagel, Ger-
many, Catalogue No. 740955) and further total RNA 
purification was done according to manufacturer’s 
instructions. The quality of the total RNA was assayed 
using a Bioanalyzer (Agilent Technologies, USA) at the 
Central Analytical Facility (Stellenbosch University, 
South Africa).
Five micrograms of total RNA was treated with Turbo 
DNase (ThermoFisher, USA, Catalogue No. AM2238) 
according to the manufacturer’s instructions. One micro-
gram of Turbo DNase-treated total RNA was used for 
cDNA synthesis using the PrimeScript™ 1st strand cDNA 
synthesis kit (TaKaRa, USA, Catalogue No. DRR037A) 
with the appropriate reverse primers (Table 1) as per man-
ufacturer’s instructions. Quantitative PCR was conducted 
using  SYBR® Premix Ex Taq™ mastermix (TaKaRa, USA, 
Catalogue No. RR82WR) on a Bio-Rad CFX96™ Real-
Time PCR Detection System (Bio-Rad, USA) with the fol-
lowing cycling conditions: initial denaturation at 95 °C for 
30 s; 39 cycles of amplification at 95 °C for 5 s followed by 
30  s at 60  °C. The subsequent melt curve started with a 
denaturation step at 95 °C for 10 s and then a melting step 
from 65 °C to 95 °C with 5 s staying at each 0.5 °C interval. 
sigA was selected as the reference gene due to its constitu-
tive expression [18]. The expression of all genes of inter-
est was normalized against that of sigA in the same RNA 
sample, which was done by dividing the number of cDNA 
copy number of mycP3 by that of sigA.
ESX‑3 promoter activity in response to iron levels
The promoter activity of the ESX-3 promoters in 
response to iron levels was assayed using RT-qPCR of 
the gene expression levels of mycP3 in WT, ΔMycP3ms, 
ΔMycP3ms::pr1MycP3ms and ΔMycP3ms::pr2MycP3ms 
strains under normal 7H9, iron deprived 7H9 and iron 
rescued 7H9 media. ΔMycP3ms strain acted as the nega-
tive control.
Statistical analysis
Differences of intracellular iron concentrations and gene 
expression levels of mycP3 between  WTms, ΔMycP3ms 
and two complementation strains under different iron 
concentrations were evaluated by Two-way ANOVA 
using GraphPad Prism 5 software. The comparison was 
considered significant when p value is smaller than 0.05.
Results
Mycobacterium smegmatis ΔMycP3 mutant showed similar 
growth as the WT under low iron conditions
MycP3 is an important component of the ESX-3 pro-
tein secretion system although its detailed function has 
not been revealed. The growth profiles of Mycobac-
terium smegmatis WT, ΔMycP3 mutant and the two 
complementation strains, ΔMycP3ms::pr1MycP3ms and 
ΔMycP3ms::pr2MycP3ms were assessed under low iron 
and iron-deprived conditions in 7H9 and Sauton’s media 
to see whether the knockout of mycP3 gene would have 
a negative impact on the bacterial growth. However, no 
major difference in the exponential growth rate and the 
starting point of exponential growth phase was observed 
between the strains in these media, although ΔMycP3 
mutant appears to have a slightly lower growth rate and 
 OD600 reading at plateau than the WT and two comple-
mentation strains in these media except for iron-depleted 
Sauton’s medium (Figs.  2, 3). The differences of end-
point bacterial loads of all strains were observed, how-
ever, it was possibly due to bacterial clumping making 
the  OD600nm reading inaccurate. Clumping of all six cul-
tures started to become visible when the growth reached 
plateau. It persisted although a range of Tween-80 con-
centrations and sonication intensity were applied to the 
culture (Results not shown).
The mycP3 gene does not impact on bacterial intracellular 
iron level
Deletion of the mycP3 gene did not significantly affect 
the growth of ΔMycP3ms under low iron conditions. But 
this does not rule out an impact on iron homeostasis, we 
therefore investigated whether mycP3 influenced bac-
terial iron acquisition by measuring intracellular iron 
levels. No significant differences between the strains 
were detected under three culturing conditions (Fig.  4). 
Intracellular iron levels dropped dramatically for all four 
strains after they were sub-cultured three times in Fe-free 
7H9 and finally in Fe-depleted 7H9, showing an approxi-
mately 75% reduction. In contrast, intracellular iron level 
rose to a significantly higher level (approximately two-
fold) when iron was added to the Fe-depleted 7H9 media 
in the same concentration as conventional 7H9 medium.
Functional analysis of the ESX‑3 promoters
We used both promoters from the esx-3 gene cluster to 
construct the  MycP3 complementation strains to see how 
the activities of the two promoters in the ESX-3 gene 
cluster in M. smemgatis differ in different iron levels. 
The promoters were incorporated into the two comple-
mentation strains separately and the strains did not show 
significant differences in either bacterial growth or myco-
bacterial intracellular iron levels under different iron 
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concentrations (Fig.  4). We then assessed the promoter 
activity by determining the mycP3 gene expression levels 
in the four strains under different iron conditions (Fig. 5). 
In iron rich conditions, mycP3 under control of the first 
promoter was expressed at similar levels as observed in 
 WTms while mycP3 expression is highly elevated under 
control of the second promoter. This expression profile 
was inverted in iron-deprived media, and restored when 
iron was added to the iron-deprived media (Fig. 5).
Discussion
This study investigated the effect of the deletion of mycP3, 
an important component of the ESX-3 protein secretion 
system, on the physiology of Mycobacterium smegmatis. 
ESX-3 has been implicated in iron homeostasis via the 
mycobactin and heme iron acquisition systems as well 
as virulence through the secretion of the EsxG-EsxH 
and PE5-PPE4 protein pairs, and is essential for in vitro 
growth of M. tuberculosis [19, 20]. It could be a source of 
potential drug targets for anti-TB drug development.
The deletion of mycP3 alone did not affect the growth 
of M. smegmatis significantly or disrupt iron homeo-
stasis, which correlates with the findings from Siegrist 
and colleagues [19]. However, deletion of ESX-3 makes 
the mycobacteria unable to grow under low iron condi-
tions [4].  MycP3 possibly does not affect the secretion 
of the ESX-3 substrates significantly [19]. The deletion 
of mycP3 might influence mycobactin-mediated iron 
acquisition, but the iron acquisition overall was not dis-
rupted because M. smegmatis possesses an alternative 
exochelin-mediated iron acquisition pathway. The exo-
chelin biosynthesis and transporters are distinct from 
those of mycobactin [7] therefore exochelin-mediated 
iron acquisition may have compensated for any potential 
malfunction of mycobactin-mediated iron acquisition. 
Interestingly, a double mutant with mycP3 deleted and 
a
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Fig. 2 Growth curves of the WT, ΔMycP3 mutant and the two complementation strains, ΔMycP3ms::pr1MycP3ms and ΔMycP3ms::pr2MycP3ms under 
Fe‑free 7H9 (a), Fe‑free Sauton’s media (b). The growth curves were done in triplicate, error bars show standard deviation
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exochelin pathway disabled does not affect the bacte-
rial growth in iron deprived media [19], suggesting that 
 MycP3 is dispensable in the function of the ESX-3.
Surprisingly, the intracellular iron levels of all of the 
studied M. smegmatis strains, when iron rescued, were 
about twofold higher than when cultured in normal 7H9 
media. This might be explained by the hypothesis that 
cell envelope-associated mycobactins serve as temporary 
storage for iron ions [21]. We reason that the production 
of mycobactin was suppressed under iron rich conditions 
through regulation by IdeR [9, 22] when first cultured 
in commercially available normal 7H9; but derepressed 
during iron deprivation to produce a large amount of 
mycobactin which was transported into the cell enve-
lope. When iron was added to rescue the iron-starved 
bacterial culture, normal iron uptake was restored mean-
while the abundant cell envelope mycobactins were able 
to bind the available iron resulting in high cellular iron 
levels. In addition, the insignificant impact of the mycP3 
gene knockout on the in vitro physiology of M. smegma-
tis is supported by the comparative proteomics between 
the  WTms and ΔMycP3ms under iron rich condition (Fang 
et al. unpublished results).
The M. smegmatis ESX-3 is expressed under the con-
trol of two promoters [8]. Previous studies did not find 
major differences in the activity of the promoters under 
various culturing conditions including iron-rich and 
iron-deprived, except during acid stress [8]. In this study, 
the two promoters responded to different iron levels in 
an inverse fashion. A possible reason for the discrepancy 
a
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Fig. 3 Growth curves of the WT, ΔMycP3 mutant and the two complementation strains, ΔMycP3ms::pr1MycP3ms and ΔMycP3ms::pr2MycP3ms under 
Fe‑depleted 7H9 (a), and Fe‑depleted Sauton’s media (b). The growth curves were done in triplicate, error bars show standard deviation
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between our and Maciag’s data is possibly due to the dif-
ferent experiment setup as they used the expression of the 
gene directly downstream of the promoters (msmeg0615 
and msmeg0620 respectively) as the reporters while we 
used mycP3 gene expression as the reporter and the pro-
moter-mycP3 couple was independent of the esx-3 cluster 
in the M. smegmatis genome. The transcription of mycP3 
from the promoter (pr1) in the ΔMycP3ms::pr1MycP3ms 
strain responds to different iron levels in the same fash-
ion as  WTms (Fig.  5) implying that the transcription of 
the mycP3 gene is controlled by the first promoter (pr1) 
even though the gene is downstream of the 2nd promoter 
(pr2) (Fig. 1). However, the transcription level of recom-
binant mycP3 under the control of the first promoter is 
significantly higher than endogenous mycP3 expression 
in  WTms. In the integrative complementation vector, 
the mycP3 gene was positioned directly downstream of 
the promoter, rather than being 9 genes downstream as 
in the  WTms genome. Such an artificial genetic arrange-
ment brings the gene closer to the transcription start site 
thereby increasing the rate of transcription, increasing 
the number of transcripts [23]. The second promoter is 
not regulated in the same manner as the first, suggest-
ing its independence from IdeR regulation. It was pro-
posed that the first promoter in the esx-3 gene cluster 
is responsible for the transcription of the entire operon 
while the second promoter only influences the tran-
scription of the 6 genes downstream of it [8]. Even when 
iron-deprived, the expression of mycP3 from the second 
promoter reached the same level as in  WTms. When iron 
was sufficient, the second promoter was up-regulated by 
an unknown mechanism, possibly to express the down-
stream ESX pair, MSMEG_0620 and MSMEG_0621, and 
secreted protein  EspG3 (MSMEG_0622), which may be 
required in other metabolic pathways or even nutrient 
acquisition [24].
Conclusion
Our study confirms that  MycP3 is dispensable to the bac-
terial growth or iron homeostasis in M. smegmatis as 
previously shown in other studies. The two promoters 
in esx-3 gene cluster respond inversely to iron-rich and 
iron-deprived conditions which was not observed previ-
ously implying that the two promoters are not redundant 
and the second promoter may regulate the production 
of the downstream genes for other metabolic activities 
Fig. 4 The comparison of the intracellular iron levels in  WTms, 
ΔMycP3ms, ΔMycP3ms::pr1MycP3ms and ΔMycP3ms::pr2MycP3ms 
strains under 7H9, Fe‑depleted 7H9 and Fe rescued 7H9 media. The 
error bars show standard error of the mean (n = 4). The p values 
obtained using two‑way ANOVA statistical analysis between different 
culturing conditions for all four strains are smaller than 0.0001 (***), 
an example is shown for the  WTms
Fig. 5 Gene expression analysis of mycP3 in  WTms, ΔMycP3ms, 
ΔMycP3ms::Pr1MycP3, and ΔMycP3ms::Pr2MycP3 strains under normal 
7H9 (iron rich), Fe‑free 7H9, and Fe‑rescued 7H9 media. The results 
were normalized against the RNA copy number of sigA. The p values 
obtained using two‑way ANOVA statistical analysis (n = 3) (*p < 0.05, 
**p < 0.01, ***p < 0.001, non‑significant comparison is not shown)
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in the bacteria which is of great interest for further 
investigation.
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2 and 3:  WTms (1674 bp); Lane 4 and 5: ΔMycP3ms (251 bp); Lane 6 and 7: 
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